Dr. Shawn Stewart Cowell, AU.D, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 17273 State Route 104, Audiology Department (126), Chillicothe, OH 45601 Phone: 740-773-1141 |
Rachel Brooke Maynard, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 272 Hospital Rd, Chillicothe, OH 45601 Phone: 740-779-7660 |
Ms. Debra L. Morgan, M.A., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159 Ste G70, Chillicothe, OH 45601 Phone: 740-779-4327 Fax: 740-779-4399 |
Dr. Sabrina D. Greer, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 4439 State Route 159 Ste G70, Chillicothe, OH 45601 Phone: 740-779-4327 Fax: 740-779-4399 |
Chelci Jo Gay, DR. Audiologist Medicare: Medicare Enrolled Practice Location: 2530 Western Ave Ste C, Chillicothe, OH 45601 Phone: 740-851-4727 |
Dr. Erica Lynn Scudder, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 138 Marietta Rd, Chillicothe, OH 45601 Phone: 740-775-4327 |
Ashtyn Rife, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 4439 State Route 159 Ste G70, Chillicothe, OH 45601 Phone: 740-779-4327 |
Dr. Stephen Richard Rizzo Jr., PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 17273 State Rt. 104, Chillicothe, OH 45601 Phone: 740-773-1141 Fax: 740-779-5506 |
Dr. Angela Beth Staley, AU.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 17273 State Route 104, Chillicothe, OH 45601 Phone: 740-773-1141 |
News Archive
The American College of Cardiology will host the ACC Latin America Conference in partnership with the Peruvian Society of Cardiology in Lima, Peru, on November 16-17, 2018, bringing together top experts to review and discuss new, relevant cardiovascular science pertinent to the region. This is the first time the conference will be held in South America.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Clonidine Hydrochloride Injection in two dosage strengths.
The Dallas Morning News reports on some of health reform's proposed changes to Medicare and local consumer reactions. "The 10.4 million beneficiaries with private insurers' Medicare Advantage plans will still get coverage at least comparable to regular Medicare, but some will see fewer extra benefits or higher out-of-pocket costs. For most of Medicare's 45 million beneficiaries, an overhaul will improve coverage by beefing up drug benefits, preserving access to physicians, paying for more preventive care and putting Medicare on firmer financial footing."
A team of scientists of the University of Oxford reveals that the nucleocapsid protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) undergoes autoproteolysis, and that resulting products can escape the host immune responses and facilitate viral proliferation. The study is currently available on the bioRxiv preprint server.
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
› Verified 4 days ago